{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:41:15Z","timestamp":1791859275725,"version":"4.3.4"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1681\/asn.2014111120","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T22:24:13Z","timestamp":1440109453000},"page":"293-304","source":"Crossref","is-referenced-by-count":283,"title":["IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury"],"prefix":"10.1681","volume":"27","author":[{"given":"Carmen","family":"Lefaucheur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Viglietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Bentlejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Duong van Huyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi","family":"Vernerey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Verine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Jouven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Glotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Loupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20230208","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"R2-31-20230208","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"R3-31-20230208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.12579","article-title":"OPTN\/SRTR 2012 annual data report: kidney.","volume":"14","author":"Matas","year":"2014","journal-title":"Am J Transplant"},{"key":"R5-31-20230208","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra0902927","article-title":"Rejection of the kidney allograft.","volume":"363","author":"Nankivell","year":"2010","journal-title":"N Engl J Med"},{"key":"R6-31-20230208","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/TP.0b013e3182777f28","article-title":"Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies.","volume":"95","author":"Papadimitriou","year":"2013","journal-title":"Transplantation"},{"key":"R7-31-20230208","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R8-31-20230208","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"key":"R9-31-20230208","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation.","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"R10-31-20230208","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival.","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"R11-31-20230208","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.178.2.661","article-title":"Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.","volume":"178","author":"Tao","year":"1993","journal-title":"J Exp Med"},{"key":"R12-31-20230208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/TP.0000000000000203","article-title":"Determinants of C1q binding in the single antigen bead assay.","volume":"98","author":"Schaub","year":"2014","journal-title":"Transplantation"},{"key":"R13-31-20230208","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri1266","article-title":"Human antibody-Fc receptor interactions illuminated by crystal structures.","volume":"4","author":"Woof","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R14-31-20230208","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/icb.2014.48","article-title":"B cells take their time: sequential IgG class switching over the course of an immune response?","volume":"92","author":"van Zelm","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"R15-31-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases.","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"R16-31-20230208","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s10096-014-2138-3","article-title":"Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.","volume":"33","author":"Azevedo","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R17-31-20230208","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/rheumatology\/41.1.62","article-title":"IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.","volume":"41","author":"Bijl","year":"2002","journal-title":"Rheumatology (Oxford"},{"key":"R18-31-20230208","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0090-1229(88)90181-X","article-title":"Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis.","volume":"46","author":"No\u00ebl","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"R19-31-20230208","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ki.1997.32","article-title":"IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis.","volume":"51","author":"Imai","year":"1997","journal-title":"Kidney Int"},{"key":"R20-31-20230208","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","article-title":"Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy.","volume":"27","author":"Qu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R21-31-20230208","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0272-6386(12)80997-8","article-title":"IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies.","volume":"23","author":"Haas","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R22-31-20230208","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.23451","article-title":"Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.","volume":"18","author":"Kaneku","year":"2012","journal-title":"Liver Transpl"},{"key":"R23-31-20230208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31821cdf0d","article-title":"Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection.","volume":"92","author":"H\u00f6nger","year":"2011","journal-title":"Transplantation"},{"key":"R24-31-20230208","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/tri.12206","article-title":"Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1\/IgG3 to noncomplement fixing IgG2\/IgG4 anti-HLA alloantibodies.","volume":"27","author":"Arnold","year":"2014","journal-title":"Transpl Int"},{"key":"R25-31-20230208","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.TP.0000136966.63957.E2","article-title":"Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential.","volume":"78","author":"Kushihata","year":"2004","journal-title":"Transplantation"},{"key":"R26-31-20230208","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00007890-199211000-00014","article-title":"The occurrence of cytotoxic and non-complement-fixing antibodies in the crossmatch serum of patients with early acute rejection episodes.","volume":"54","author":"Karuppan","year":"1992","journal-title":"Transplantation"},{"key":"R27-31-20230208","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/01.TP.0000129408.07168.40","article-title":"Skewing of pretransplant anti-HLA class I antibodies of immunoglobulin G isotype solely toward immunoglobulin G1 subclass is associated with poorer renal allograft survival.","volume":"77","author":"Griffiths","year":"2004","journal-title":"Transplantation"},{"key":"R28-31-20230208","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.tp.0000256337.18347.aa","article-title":"Determinants of the complement-fixing ability of recipient presensitization against HLA antigens.","volume":"83","author":"Bartel","year":"2007","journal-title":"Transplantation"},{"key":"R29-31-20230208","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/tri.12230","article-title":"The complexity of the humoral immune response against HLA antigens.","volume":"27","author":"Schaub","year":"2014","journal-title":"Transpl Int"},{"key":"R30-31-20230208","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0041-1345(96)00541-6","article-title":"Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.","volume":"29","author":"Monteiro","year":"1997","journal-title":"Transplant Proc"},{"key":"R31-31-20230208","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0272-6386(96)90136-5","article-title":"Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.","volume":"28","author":"Regan","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R32-31-20230208","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.humimm.2004.08.182","article-title":"Detection and specification of noncomplement binding anti-HLA alloantibodies.","volume":"65","author":"Arnold","year":"2004","journal-title":"Hum Immunol"},{"key":"R33-31-20230208","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/lt.20154","article-title":"Immunoglobulin-G subclass antidonor reactivity in transplant recipients.","volume":"10","author":"Gao","year":"2004","journal-title":"Liver Transpl"},{"key":"R34-31-20230208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trim.2010.03.003","article-title":"Subtypes of immunoglobulin (Ig)-G antibodies against donor class II HLA and cross-match results in three kidney transplant candidates.","volume":"23","author":"Lobashevsky","year":"2010","journal-title":"Transpl Immunol"},{"key":"R35-31-20230208","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R37-31-20230208","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"R38-31-20230208","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.transproceed.2013.02.062","article-title":"Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports.","volume":"45","author":"Kocak","year":"2013","journal-title":"Transplant Proc"},{"key":"R39-31-20230208","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/TP.0000000000000184","article-title":"Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts.","volume":"98","author":"Burbach","year":"2014","journal-title":"Transplantation"},{"key":"R40-31-20230208","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.humimm.2013.01.008","article-title":"Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response.","volume":"74","author":"Lowe","year":"2013","journal-title":"Hum Immunol"},{"key":"R41-31-20230208","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(04)17142-0","article-title":"Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies.","volume":"364","author":"Debiec","year":"2004","journal-title":"Lancet"},{"key":"R42-31-20230208","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1681\/ASN.2006050497","article-title":"Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies.","volume":"17","author":"Ronco","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R43-31-20230208","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"key":"R44-31-20230208","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-6143.2004.00334.x","article-title":"Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts.","volume":"4","author":"Rahimi","year":"2004","journal-title":"Am J Transplant"},{"key":"R45-31-20230208","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrneph.2012.212","article-title":"The role of complement in antibody-mediated rejection in kidney transplantation.","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R46-31-20230208","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R47-31-20230208","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R48-31-20230208","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R49-31-20230208","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions.","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201601000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:54Z","timestamp":1786130814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201601000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014111120","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}